0
6

[–] nycpats 0 points 6 points (+6|-0) ago 

The answer is yes.

0
2

[–] ketoll 0 points 2 points (+2|-0) ago  (edited ago)

Always research to see if anything links back to one of the following:

  • Pfizer

  • Novartis

  • Roche

  • Sanofi

  • Merck & Co.

  • GlaxoSmithKline (GSK)

These are the top 6 Pharma companies in the world, and they spend a lot of money on PR, advertising, and other campaigns to keep their drugs and vaccines flowing.

There is also:

  • China Resources

  • Johnson & Johnson

  • Sinopharm

  • Bayer

We must know their names and know where to trace things back to.

0
0

[–] EuropeNeedsFixing ago 

You forgot Gilead Science, which owns the rights to Remdesivir, that is now promoted as "The Cure"...

0
2

[–] Pluviophile 0 points 2 points (+2|-0) ago 

Yes.

Next question.

0
0

[–] rickki6 [S] ago 

lOl !

1
1

[–] IamCasper 1 point 1 point (+2|-1) ago  (edited ago)

Yes, and big pharma also controls the main stream media with ad revenue. All the Nightly News ever plays is ads for prescription drugs, and those are prime time ads.

0
1

[–] tweety51 0 points 1 point (+1|-0) ago 

It seems like the negligence and lack of due diligence by many in power are directly responsible for many deaths. It is tragic how they are treating people in nursing homes. They could have saved many lives with an appropriate protocol. Hopefully they will be held accountable.

2
-2

[–] AlternateSelection 2 points -2 points (+0|-2) ago 

LOL Still have hope? LOLOLOL

0
1

[–] User890020 0 points 1 point (+1|-0) ago 

yes

0
0

[–] Rgladstone ago 

Study confirms..... treatment.

https://pubmed.ncbi.nlm.nih.gov/16115318/

0
0

[–] arcoflight ago 

My only disagreement is that Big Pharma was at war with HCQ before Pres. Trump mentioned it, just by silence they buried it, and made sure none heard about it. When Pres. Trump raised it they were suddenly on defence and have fully utilized TDS to block the message as best they can. I think big Pharma lost a lot of ground to this Trump offensive.

load more comments ▼ (3 remaining)